Edition:
United States

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

219.36USD
23 May 2017
Change (% chg)

-- (--)
Prev Close
$219.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,178
52-wk High
$224.24
52-wk Low
$136.01

BIO.N

Chart for BIO.N

About

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $6,471.57
Shares Outstanding(Mil.): 29.58
Dividend: --
Yield (%): --

Financials

  BIO.N Industry Sector
P/E (TTM): 231.37 31.20 17.36
EPS (TTM): 0.95 -- --
ROI: 0.82 12.79 -5.72
ROE: 1.08 15.28 -5.10

BRIEF-Amicogen buys 9.1 pct stake in Bio-Works Technologies AB

* Says it has acquired 895,000 shares in Bio-Works Technologies AB, and is holding 9.1 percent stake in the co, from 0 percent stake

May 18 2017

BRIEF-Autobio Diagnostics to invest in 75 pct stake in bio-tech firm Bio-top

* Says it plans to invest up to 202.5 million yuan ($29.32 million) for 75 percent stake in Beijing-based bio-tech firm Bio-top

May 09 2017

BRIEF-Bio-Rad Laboratories reports Q1 earnings per share $0.41

* Q1 revenue $500.1 million versus I/B/E/S view $477.8 million

May 04 2017

Fitch Affirms Bio-Rad's IDR at 'BBB-'; Outlook Stable

(The following statement was released by the rating agency) AUSTIN, April 05 (Fitch) Fitch Ratings has affirmed the ratings of Bio-Rad Laboratories, Inc. (Bio-Rad), including the 'BBB-' Issuer Default Rating (IDR). The ratings apply to approximately $437 million of debt at Dec. 31, 2016. The Rating Outlook is Stable. A full list of rating actions follows at the end of this release. KEY RATING DRIVERS Evolving Capital Allocation Strategy: Bio-Rad recently announced long-term targets for revenue g

Apr 05 2017

BRIEF-Bio Rad Laboratories management intends to three people for election to its board

* Management intends to propose Jeffrey Edwards, Gregory Hinckley and Arnold Pinkston for election to its board of directors

Mar 13 2017

BRIEF-Bio-Rad to acquire Raindance Technologies, Droplet Intellectual Property

* Bio-Rad to acquire Raindance Technologies and Droplet Intellectual Property

Jan 16 2017

More From Around the Web

Earnings vs. Estimates